Defining the target: clinical aims in axial spondyloarthritis

por Marzo-Ortega, Helena, Gaffney, Katie M, Gaffney, Karl
Publicado 2018

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort

por Al Arashi, Wala, Iñiguez Ubiaga, Carlota, Hensor, Elizabeth M, Gaffney, Katie, Freeston, Jane, Vandevelde, Claire, Barr, Andrew, van der Horst-Bruinsma, Irene, Marzo-Ortega, Helena
Publicado 2018